Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Cobicistat & elvitegravir & emtricitabine & tenofovir disoproxil fumarate, Cobicistat + elvitegravir + emtricitabine + tenofovir disoproxil fumarate, Cobicistat and elvitegravir and emtricitabine and tenofovir disoproxil fumarate, Quad, Quad pill, Quad tablet
Molecular Formula
C94H120ClF2N16O27PS3
Molecular Weight
2106.7  g/mol
InChI Key
FMCLRHTZMTUYMI-JFQFMQNHSA-N

A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid;6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid;1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
2.1.2 InChI
InChI=1S/C40H53N7O5S2.C23H23ClFNO5.C19H30N5O10P.C8H10FN3O3S.C4H4O4/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35;1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25;1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5;5-3(6)1-2-4(7)8/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49);4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30);7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1,5-6,13H,2-3H2,(H2,10,11,14);1-2H,(H,5,6)(H,7,8)/b;;;;2-1+/t32-,33-,36+;19-;14-;5-,6+;/m1110./s1
2.1.3 InChI Key
FMCLRHTZMTUYMI-JFQFMQNHSA-N
2.1.4 Canonical SMILES
CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5.CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O.CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C.C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F.C(=CC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5.CC(C)[C@@H](CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O.C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F.C(=C/C(=O)O)\C(=O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination

2. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate

3. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate Drug Combination

4. Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

5. Elvitegravir-cobicistat-emtricitabine-tenofovir Disoproxil Fumarate Drug Combination

6. Genvoya

7. Pill, Quad

8. Quad Pill

2.2.2 Depositor-Supplied Synonyms

1. Cobicistat & Elvitegravir & Emtricitabine & Tenofovir Disoproxil Fumarate

2. Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Disoproxil Fumarate

3. Cobicistat And Elvitegravir And Emtricitabine And Tenofovir Disoproxil Fumarate

4. Quad

5. Quad Pill

6. Quad Tablet

7. Evg-cobi-ftc-tdf

8. Cobicistat, Elvitegravir, Emtricitabine, Tenofovir

9. Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil

10. Elvitegravir-cobicistat-emtricitabine-tenofovir Disoproxil Fumarate

11. Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil Fumarate

12. Cobicistat Mixture With Elvitegravir And Emtricitabine And Tenofovir Disoproxil

13. Cobicistat Mixture With Elvitegravir, Emtricitabine And Tenofovir Disoproxil Fumarate

14. Elvitegravir Mixture With Cobicistat And Emtricitabine And Tenofovir Disoproxil Fumarate

15. Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

16. 1430117-57-9

2.3 Create Date
2009-10-19
3 Chemical and Physical Properties
Molecular Weight 2106.7 g/mol
Molecular Formula C94H120ClF2N16O27PS3
Hydrogen Bond Donor Count10
Hydrogen Bond Acceptor Count40
Rotatable Bond Count48
Exact Mass2105.7098720 g/mol
Monoisotopic Mass2104.7065172 g/mol
Topological Polar Surface Area655 Ų
Heavy Atom Count144
Formal Charge0
Complexity3010
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameStribild
PubMed HealthElvitegravir/Cobicistat/Emtricitabine/Tenofovir (By mouth)
Drug ClassesAnti-Infective Agent, Antiviral, Reverse Transcriptase Inhibitor Combination
Drug LabelSTRIBILD is a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir DF for oral administration.Elvitegravir is an HIV-1 integrase strand transfer inhibitor.Cobicistat is a mechanism-based inhibitor of cytochr...
Active Ingredientelvitegravir; Cobicistat; tenofovir disoproxil fumarate; emtricitabine
Dosage FormTablet
RouteOral
Strength200mg; 150mg; 300mg
Market StatusPrescription
CompanyGilead Sciences

2 of 2  
Drug NameStribild
PubMed HealthElvitegravir/Cobicistat/Emtricitabine/Tenofovir (By mouth)
Drug ClassesAnti-Infective Agent, Antiviral, Reverse Transcriptase Inhibitor Combination
Drug LabelSTRIBILD is a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir DF for oral administration.Elvitegravir is an HIV-1 integrase strand transfer inhibitor.Cobicistat is a mechanism-based inhibitor of cytochr...
Active Ingredientelvitegravir; Cobicistat; tenofovir disoproxil fumarate; emtricitabine
Dosage FormTablet
RouteOral
Strength200mg; 150mg; 300mg
Market StatusPrescription
CompanyGilead Sciences

4.2 Drug Indication

Treatment of human immunodeficiency virus 1 (HIV 1) infection in adults aged 18 years and over who are antiretroviral treatment-nave or are infected with HIV 1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-HIV Agents

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)


5.2 ATC Code

J05AR09